Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury

Brief Summary

The purpose of this study is to identify the optimal dosing strategy for low-dose ketamine infusions in adult acute burn injury patients when used with usual pain medications.

Intervention / Treatment

  • Drug: Ketamine
  • Drug: Opioids

Condition or Disease

  • Pain

Phase

Study Design

Study type: Interventional
Status: Withdrawn
Study results: No Results Available
Age: 18 Years and older   (Adult, Older Adult)
Enrollment: 0 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Apr 01, 2017
Primary Completion: May 24, 2018
Completion Date: May 24, 2018
Study First Posted: Mar 29, 2017
Results First Posted: Aug 31, 2020
Last Updated: Oct 31, 2018

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

This Aim will identify the safest and most optimal dosing strategy for low-dose ketamine infusions. While the hourly rate for low-dose ketamine infusions used for adjunctive analgesia appears to be well-established both in the medical literature and our institutional protocols, there is no information available for this specific population of patients (adult acute burn injury) to know whether the infusions should be utilized for discrete periods of time or should be given continuously. Findings from this study will help provide preliminary data on the optimal dosing strategy of this medication for adjunctive analgesia in this population.

Eligibility Criteria

Sex: All
Minimum Age: 18

More Details

NCT Number: NCT03095222
Other IDs: STUDY00004424
Study URL: https://ClinicalTrials.gov/show/NCT03095222
Last updated: Jun 17, 2022